Perpetuum, a member of UK-based Nanotechnology Knowledge Transfer Network (NanoKTN), has developed a new implantable self-energising pacemaker. Designed to generate energy from human power, it eliminates the need to periodically replace batteries, thus reducing costs and patient discomfort.
During testing, the self-energising pacemaker was found to be easily implanted. It works by harvesting vibrational energy from the changing pressure of the heart during the cardiac cycle.
Perpetuum president Roy Freeland said the company believes support from the UK-based Technology Strategy Board and NanoKTN director Dr Alec Reader had a significant impact on its success and in securing the funding, which was integral to the pacemaker technology’s development.
"As members of the NanoKTN we have been given a huge amount of exposure, not only by attending events but through recommendations and by presenting at conferences and workshops alongside peers and partners in the industry," Freeland said.
"The NanoKTN activities have not only helped raise our profile within key market sectors but have also provided a platform to showcase our technology to key target audiences and interested stakeholders.
"The NanoKTN has been invaluable to us as a business and especially now, as we research potential international partners and licenses to launch the pacemaker technology worldwide."
Nanotechnology Knowledge Transfer Network director Dr Alec Reader said; "We believe that energy harvesting technologies will see significant growth in the coming years, already representing a £1bn industry and we believe the technology being developed by Perpetuum will have many potential market applications."
The pacemaker was presented at a recent workshop hosted by the NanoKTN as part of S2K 2012.